Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation

Mayo Clinic40 enrolled

Overview

The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Liver Transplantation

Interventions

ECOM ETTDEVICE

Intubation with ECOM endotracheal tube (ETT)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients undergoing liver transplantation surgery Exclusion Criteria: * Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.

Locations (1)

Mayo Clinic

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive

Pulmonary artery catheters are a standard of care for intraoperative hemodynamic assessment during liver transplantation. We propose to compare hemodynamic parameters obtained from PA catheters and ECOM. Use the endotracheal cardiac output monitor (ECOM) to evaluate multiple hemodynamic parameters (invasive blood pressure from the indwelling arterial catheter, noninvasive cardiac output via ECOM), and compare these to the parameters obtained from PA catheter.

Time frame: Less than 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.